Literature DB >> 30679277

Human coronaviruses OC43 and HKU1 bind to 9-O-acetylated sialic acids via a conserved receptor-binding site in spike protein domain A.

Ruben J G Hulswit1, Yifei Lang1, Mark J G Bakkers1, Wentao Li1, Zeshi Li2, Arie Schouten3, Bram Ophorst1, Frank J M van Kuppeveld1, Geert-Jan Boons2,4,5, Berend-Jan Bosch1, Eric G Huizinga3, Raoul J de Groot6.   

Abstract

Human betacoronaviruses OC43 and HKU1 are endemic respiratory pathogens and, while related, originated from independent zoonotic introductions. OC43 is in fact a host-range variant of the species Betacoronavirus-1, and more closely related to bovine coronavirus (BCoV)-its presumptive ancestor-and porcine hemagglutinating encephalomyelitis virus (PHEV). The β1-coronaviruses (β1CoVs) and HKU1 employ glycan-based receptors carrying 9-O-acetylated sialic acid (9-O-Ac-Sia). Receptor binding is mediated by spike protein S, the main determinant of coronavirus host specificity. For BCoV, a crystal structure for the receptor-binding domain S1A is available and for HKU1 a cryoelectron microscopy structure of the complete S ectodomain. However, the location of the receptor-binding site (RBS), arguably the single-most important piece of information, is unknown. Here we solved the 3.0-Å crystal structure of PHEV S1A We then took a comparative structural analysis approach to map the β1CoV S RBS, using the general design of 9-O-Ac-Sia-binding sites as blueprint, backed-up by automated ligand docking, structure-guided mutagenesis of OC43, BCoV, and PHEV S1A, and infectivity assays with BCoV-S-pseudotyped vesicular stomatitis viruses. The RBS is not exclusive to OC43 and related animal viruses, but is apparently conserved and functional also in HKU1 S1A The binding affinity of the HKU1 S RBS toward short sialoglycans is significantly lower than that of OC43, which we attribute to differences in local architecture and accessibility, and which may be indicative for differences between the two viruses in receptor fine-specificity. Our findings challenge reports that would map the OC43 RBS elsewhere in S1A and that of HKU1 in domain S1B.

Entities:  

Keywords:  9-O-acetylated sialic acid; HKU1; OC43; coronavirus; spike

Mesh:

Substances:

Year:  2019        PMID: 30679277      PMCID: PMC6377473          DOI: 10.1073/pnas.1809667116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  138 in total

1.  A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies.

Authors:  Chunyan Wang; Rien van Haperen; Javier Gutiérrez-Álvarez; Wentao Li; Nisreen M A Okba; Irina Albulescu; Ivy Widjaja; Brenda van Dieren; Raul Fernandez-Delgado; Isabel Sola; Daniel L Hurdiss; Olalekan Daramola; Frank Grosveld; Frank J M van Kuppeveld; Bart L Haagmans; Luis Enjuanes; Dubravka Drabek; Berend-Jan Bosch
Journal:  Nat Commun       Date:  2021-03-17       Impact factor: 14.919

2.  Synthetic O-acetylated sialosides facilitate functional receptor identification for human respiratory viruses.

Authors:  Zeshi Li; Yifei Lang; Lin Liu; Mehman I Bunyatov; Angelic Isaza Sarmiento; Raoul J de Groot; Geert-Jan Boons
Journal:  Nat Chem       Date:  2021-03-22       Impact factor: 24.427

Review 3.  Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review.

Authors:  Adeel S Zubair; Lindsay S McAlpine; Tova Gardin; Shelli Farhadian; Deena E Kuruvilla; Serena Spudich
Journal:  JAMA Neurol       Date:  2020-08-01       Impact factor: 18.302

4.  Sialoglycovirology of Lectins: Sialyl Glycan Binding of Enveloped and Non-enveloped Viruses.

Authors:  Nongluk Sriwilaijaroen; Yasuo Suzuki
Journal:  Methods Mol Biol       Date:  2020

5.  Structural basis for broad coronavirus neutralization.

Authors:  Maximilian M Sauer; M Alejandra Tortorici; Young-Jun Park; Alexandra C Walls; Leah Homad; Oliver J Acton; John E Bowen; Chunyan Wang; Xiaoli Xiong; Willem de van der Schueren; Joel Quispe; Benjamin G Hoffstrom; Berend-Jan Bosch; Andrew T McGuire; David Veesler
Journal:  Nat Struct Mol Biol       Date:  2021-05-12       Impact factor: 15.369

Review 6.  Neurological pathogenesis of SARS-CoV-2 (COVID-19): from virological features to clinical symptoms.

Authors:  Yoshitaka Kase; Hideyuki Okano
Journal:  Inflamm Regen       Date:  2021-05-07

7.  Modified Sialic Acids on Mucus and Erythrocytes Inhibit Influenza A Virus Hemagglutinin and Neuraminidase Functions.

Authors:  Karen N Barnard; Brynn K Alford-Lawrence; David W Buchholz; Brian R Wasik; Justin R LaClair; Hai Yu; Rebekah Honce; Stefan Ruhl; Petar Pajic; Erin K Daugherity; Xi Chen; Stacey L Schultz-Cherry; Hector C Aguilar; Ajit Varki; Colin R Parrish
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

8.  Increased Incidence, Morbidity, and Mortality in Human Coronavirus NL63 Associated with ACE Inhibitor Therapy and Implication in SARS-CoV-2 (COVID-19).

Authors:  Armin Krvavac; Tarang P Patel; Ethan M Karle; Nicholas B Epstein; Elizabeth A Reznikov; Lancer G Gates; Zachary M Holliday
Journal:  Mo Med       Date:  2020 Jul-Aug

Review 9.  Coronavirus Receptors as Immune Modulators.

Authors:  Charan Kumar V Devarakonda; Emily Meredith; Mallika Ghosh; Linda H Shapiro
Journal:  J Immunol       Date:  2020-12-30       Impact factor: 5.422

10.  From examining the relationship between (corona)viral adhesins and galectins to glyco-perspectives.

Authors:  Michael L Klein; Antonio Romero; Herbert Kaltner; Virgil Percec; Hans-Joachim Gabius
Journal:  Biophys J       Date:  2020-11-26       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.